🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Selina Chen‐Kiang

NewYork–Presbyterian Hospital

ORCID: 0000-0002-8549-6177

Also affiliated with Cornell University, New York Hospital Queens, Presbyterian Hospital, Weill Cornell Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma”.

PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023009906
N/A
0.607DataRank · unranked
16 citations

Inah Hwang, Shelby Sloan, Claire Hinterschied, JoBeth Helmig-Mason, Mackenzie Long +19 more

CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis

UNC Libraries(2020)10.17615/g3ce-pk37
N/A
0.510DataRank · unranked
29 citations

David S. Franklin, Yue Xiong, Robert Schoonhoven, Hayyong Lee, Lishan Su +3 more

A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas

Journal of Clinical Investigation(2022)10.1172/jci160767
N/A
0.494DataRank · unranked
26 citations

Inah Hwang, Heng Pan, Jun Yao, Lapo Alinari, Eddie L. Imada +19 more

A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells

Experimental Hematology and Oncology(2022)10.1186/s40164-022-00293-y
N/A
0DataRank · unranked
10 citations

Pushpa Lata, Youssef Youssef, Ha Tran, Liudmyla Tsyba, Lalit Sehgal +15 more

Resistance to PRMT5-targeted therapy in mantle cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023010554
N/A
0DataRank · unranked
11 citations

Shirsha Koirala, Shelby Sloan, Fiona Brown-Burke, Christoph Weigel, Lynda Villagomez +19 more

Cell Cycle Dysregulation in Mantle Cell Lymphoma

Hematology/Oncology Clinics of North America(2020)10.1016/j.hoc.2020.05.003
N/A
0DataRank · unranked
15 citations

Xiangao Huang, Maurizio Di Liberto, Selina Chen‐Kiang, Kevin Wang

Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment Resistance

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.02.673601
N/A
0DataRank · unranked
0 citations

Helgi Nikolli, Belem Yoval‐Sánchez, Sieun Yang, Peter Martin, Caitlin Gribbin +12 more

Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3871
N/A
0DataRank · unranked
71 citations

Aitziber Buqué, Takahiro Yamazaki, Norma Bloy, Maurizio Di Liberto, Selina Chen‐Kiang +3 more

CDK Inhibitor p18INK4c Is Required for the Generation of Functional Plasma Cells

UNC Libraries(2021)10.17615/43as-2v68
N/A
0DataRank · unranked
0 citations

Josie Ursini‐Siegel, Ian C. M. MacLennan, David Franklin, Yue Xiong, Meihong Chen +7 more